Advertisement

Kongreß pp 202-213 | Cite as

Diabetische Polyneuropathien

  • F. A. Gries
  • H. Berger
  • I. Cicmir
  • K. Wiefels
  • D. Ziegler
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 93)

Zusammenfassung

Zentrale und periphere, willkürliche und autonome Funktionen des Nervensystems sind in ausgeprägter Weise stoffwechselabhängig. Verlust der Stoffwechselhomöostase hat in der Regel Funktionsstörungen des Nervensystems zur Folge.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bennett T (1983) Physiological investigation of diabetic autonomic failure. In: Bannister R (ed) Autonomie Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford University Press, Oxford, p 406–436Google Scholar
  2. 2.
    Boulten AJM, Drury J, Carke B, Ward JD (1982) Continuous subeutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390CrossRefGoogle Scholar
  3. 3.
    Boulten AJM, Hardisty CA, Belts RP, Franks CI, Worth RC, Ward JD, Duckwarth T (1983) Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6: 23–33CrossRefGoogle Scholar
  4. 4.
    Boutros G, Insler MS (1984) Reversible pupillary miosis during a hyperglycemic episode: Case report. Diabetologia 27: 50–51PubMedCrossRefGoogle Scholar
  5. 5.
    Bradley WE (1980) Aspects of diabetic autonomic neuropathy (workshop with fifteen articles). Am Int Med 92: 289–342Google Scholar
  6. 6.
    Campbell IW, Heading RC, Tothill P, Buist TAS, Ewing DJ, Clarke BF (1980) Gastric emptying in diabetic autonomic neuropathy. In: Gries FA, Freund HJ, Rabe F, Berger H (eds) Aspects of autonomic neuropathy in diabetes. Horm Metab Res Suppl. Series 9: 81–86Google Scholar
  7. 7.
    Caviezel F, Picotti GB, Barmonato A, Slaviero G, Galva MD, Camagna P, Bondiolotti GP, Carruba MO, Pozza G (1982) Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathetic Stimulation. Diabetologia 23: 19–23PubMedCrossRefGoogle Scholar
  8. 8.
    Christensen NJ (1979) Catecholamines and diabetes mellitus. Diabetologia 16: 211–224PubMedCrossRefGoogle Scholar
  9. 9.
    Cicmir I, Berger H, Gries FA (1983) Die diabetische Polyneuropathie. Dtsch Ärztebl 80: 25–31Google Scholar
  10. 10.
    Cicmir I, Berger H, Koschinsky T, Gries FA (1983) Quantifizierung der autonomen diabetischen Neuropathie an Herz und Auge. In: Miehlke K (Hrsg) Verhandlungen der Deutschen Gesellschaft für Innere Medizin, 89. Band. Bergmann, München, pp 702–704Google Scholar
  11. 11.
    Cicmir I, Kashiwagi S, Berger H, Koschinsky T, Gries FA (1983) Improvement of autonomic nerve funetion after on year of continuous subeutaneous insulin infusion. Diabetologia 25: 147 (Abstract)Google Scholar
  12. 12.
    Cicmir I, Petersohn A, Petersohn HJ, Berger H, Koschinsky T, Kashiwagi S, Gries FA (1984) Ursachen der rasch und langsam reversiblen Störungen der autonomen Nerven-funktion am Herzen bei Typ-I-Diabetikern. In: Miehlke K (Hrsg) Verhandlungen der Deutschen Gesellschaft für Innere Medizin, 90. Band. Bergmann, München, pp 485–488Google Scholar
  13. 13.
    Clarke BF, Campbell IW, Ewing DJ (1980) Prognosis in diabetic autonomic neuropathy. In: Gries FA, Freund HJ, Rabe F, Berger H (eds) Aspects of autonomic neuropathy in diabetes. Horm Metab Res Suppl. Series 9: 101–104Google Scholar
  14. 14.
    Clarke BF, Ewing DJ, Campbell IW (1979) Diabetic autonomic neuropathy. Diabetologia 17: 192–195CrossRefGoogle Scholar
  15. 15.
    Clements RS, Vourganti B, Kuba T (1979) Dietary myoinositol intake and peripheral nerve funetion in diabetic neuropathy. Metabolism 28: 477–483PubMedCrossRefGoogle Scholar
  16. 16.
    Cryer PE, Gerich JE (1983) Relevance of glucose counterregulary systems to patients with diabetes: critical roles of glucagon and epinephrine. Diabetes Care 6: 95–99PubMedCrossRefGoogle Scholar
  17. 17.
    Edmonds ME, Roberts VC, Watkins PJ (1982) Blood flow in the diabetic neuropathic foot. Diabetologia 23: 9–15CrossRefGoogle Scholar
  18. 18.
    Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of autonomic neuropathy. Q J Med 49: 95–108PubMedGoogle Scholar
  19. 19.
    Ewing DJ, Clarke BF (1986) Diabetic autonomic neuropathy: Present insights and future prospects. Diabetes Care 9: 648–665PubMedGoogle Scholar
  20. 20.
    Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardio vascular autonomic funetion test: 10 years experience in diabetes. Diabetes Care 8: 491–498PubMedCrossRefGoogle Scholar
  21. 21.
    Fagius J, Brattberg A, Jameson S, Berne C (1985) Limited benefit of treatment of diabetic polyneuropathy with an aldose reduetase inhibitor: a 24-week controlled trial. Diabetologia 23: 323–329Google Scholar
  22. 22.
    Faser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF (1977) Peripheral and autonomic nerve funetion in newly diagnosed diabetes mellitus. Diabetes 26: 546–550CrossRefGoogle Scholar
  23. 23.
    Fedele D, Bellavere F, Cardone C, Ferri M, Crepaldi G (1985) Improvement of cardiovascular autonomic reflexes after amelioration of metabolic control in insulin-dependent diabetic subjects with severe autonomic neuropathy. Horm Metab Res 17: 410–413PubMedCrossRefGoogle Scholar
  24. 24.
    Gambardella S, Papoli A, Spallone V, Verrastro AM, Lazzari R, Geraldine C, Sideri G, Menzinger D (1983) Influence of gluco-regulation with continuous subeutaneous insulin infusion on nerve conduction velocity and beat-to-beat Variation in diabetics. J Endocrinol Invest 6: 363–367PubMedGoogle Scholar
  25. 25.
    Garcia MJ, McNamara PM, Görden T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23: 105–111PubMedGoogle Scholar
  26. 26.
    Gillon KRW, Hawthorne JN, Tomlinson DR (1983) Myo-Inositol and Sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition. Diabetologia 25: 365–371PubMedCrossRefGoogle Scholar
  27. 27.
    Greene DA, Lattimer SA (1984) Action of sorbinil in diabetic peripheral nerve, relationship of polyol (sorbitol) pathway inhibition to a myoinositol-mediated defect in sodium-potassium ATPase activity. Diabetes 33: 712–716PubMedCrossRefGoogle Scholar
  28. 28.
    Greene DA, Lattimer S, Ulbrecht J, Carroll P (1985) Glucose-induced alterations in nerve metabolism: Current perspective in the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8: 290–299PubMedCrossRefGoogle Scholar
  29. 29.
    Gregersen G (1968) Variations in motor conduction velocity produced by acute changes of the metabolic State in diabetic patients. Diabetologia 4: 273–277PubMedCrossRefGoogle Scholar
  30. 30.
    Gries FA, Cicmir I, Kashiwagi S, Wiefels K, Berger H, Ziegler D (1986) Changes of autonomic and peripheral nerve functions in type I diabetics. Pediatr Adolsc Endocrinol 15: 262–264Google Scholar
  31. 31.
    Hilsted J, Madsbad S, Krarup T, Tronier B, Galbo H, Sestoft TL, Schwartz TW (1982) No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 54: 815PubMedCrossRefGoogle Scholar
  32. 32.
    Hreidarson AB (1981) Acute, reversible autonomic nervous system abnormalities in juvenile insulin-dependent diabetes. A pupillographic study. Diabetologia 20: 475–481CrossRefGoogle Scholar
  33. 33.
    Kashiwagi S, Wiefels K, Ziegler D, Cicmir I, Gries FA (1985) Effects of near-normoglycemia in diabetic neuropathy under treatment with continuous subcutaneous insulin infusion (CSU) In: Hepp KD, Renner R (eds) Continuous insulin infusion therapy. Schattauer, Stuttgart New York, pp 175–181Google Scholar
  34. 34.
    Ludin HP, Tackmann W (eds) Polyneuropathien. Thieme, StuttgartGoogle Scholar
  35. 35.
    Mäher TD (1980) Glucagon response to hypoglycemia in diabetic neuropathy. In: Gries FA, Freund HJ, Rabe F, Berger H (eds) Aspects of autonomic neuropathy in diabetes. Horm Metab Res Suppl. Series 9: 87–89Google Scholar
  36. 36.
    Mayer JH, Tomlinson DR (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myoinositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433–438PubMedCrossRefGoogle Scholar
  37. 37.
    Mayer P, Cicmir I, Ziegler D, Gries FA (1986) Ist eine hochdosierte parenterale Langzeittherapie mit Thioctsäure oder Vitamin B1 bei Patienten mit diabetischer Polyneuropathie sinnvoll? Akt Endokrinol Stoffwechsel 7: 94 (abstract)Google Scholar
  38. 38.
    Neundörfer B, Sailer D (1986) Interdisziplinäre Bestandsaufnahme der Polyneuropathien. Perimed, ErlangenGoogle Scholar
  39. 39.
    Pfeiffer MA, Weinberg CR, Cook DL, Reenan A, Halter J, Ensinck JW, Porte D (1984) Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7: 447–453CrossRefGoogle Scholar
  40. 40.
    Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671PubMedCrossRefGoogle Scholar
  41. 41.
    Pirart J (1978) Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188Google Scholar
  42. 42.
    Sachse G, Neuzner J, Federlin K (1983) Treatment with a portable insulin infusion system infhiences autonomic diabetic neuropathy of the cardiovascular system. In: Irsigler K, Kritz H, Lovett R (eds) Diabetes Treatment with Implantable Insulin Infusion Systems. Urban & Schwarzenberg, München, pp 201–206Google Scholar
  43. 43.
    Schiffter R (1985) Neurologie des vegetativen Systems. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  44. 44.
    Service FJ, Rizza RA, Daube JR, O’Brien PC, Dyck PJ (1985) Near normoglycemia improved nerve conduction Vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727PubMedGoogle Scholar
  45. 45.
    Strian F, Haslbeck M (1986) Autonome Neuropathie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  46. 46.
    Teutloff H (1982) Begleiterkrankungen bei Diabetes mellitus. Diss. Univ. DüsseldorfGoogle Scholar
  47. 47.
    Vogelberg KH, Kübler HGW (1985) Magenentleerung und Blutglucose bei insulinpflichtigem Diabetes mellitus mit autonomer Neuropathie. Dtsch Med Wochenschr 110: 1249–1253PubMedCrossRefGoogle Scholar
  48. 48.
    Vogelberg KH, Rathmann W (1986) Sonographische Kriterien zur Untersuchung der Magenmotilität bei Diabetikern mit autonomer Neuropathie. Dtsch Med Wochenschr 111: 1687–1691PubMedCrossRefGoogle Scholar
  49. 49.
    Ward JD, Barnes CG, Fisher DJ, Jessop FD, Baker RW (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1: 428–430PubMedCrossRefGoogle Scholar
  50. 50.
    Watkins PJ, Edmonds ME (1983) Sympathetic nerve failure in diabetes. Diabetologia 25: 73–77PubMedCrossRefGoogle Scholar
  51. 51.
    Watkins PJ, Edmonds ME (1983) Clinical presentation of diabetic autonomic failure. In: Bannister R (ed) Autonomic Failure. A Textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, pp 337–370Google Scholar
  52. 52.
    Young RJ, EwingDJ, Clarke BF (1983) Nerve function and metabolic control in teenager diabetics. Diabetes 32: 142–147PubMedCrossRefGoogle Scholar
  53. 53.
    Young RJ, Ewing DJ, Clarke BF (1983) A controlled trial of Sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 32: 938–942PubMedCrossRefGoogle Scholar
  54. 54.
    Ziegler D, Cicmir J, Mayer P, Wiefels K, Gries FA (1986) Peripheral and autonomic nerve dysfunction in newly diagnosed insulin-dependent diabetes. Transplant Proc 18: 1593–1594Google Scholar
  55. 55.
    Ziegler D, Cicmir I, Wiefels K, Berger H, Gries FA (1987) Peripheral and autonomic nerve function in long-term insulin-dependent diabetes. Diabetes Research 4: 9–14PubMedGoogle Scholar
  56. 56.
    Ziegler D, Wiefels K, Kashiwagi S, Schleppinghoff B, Dannehl K (1986) The Düsseldorf Study: Effect of 18 months of near normoglycaemia on peripheral nerve Syndrom in type 1 (insulin dependent) diabetic patients. Diabetologia 29: 609AGoogle Scholar

Copyright information

© J. F. Bergmann Verlag, München 1987

Authors and Affiliations

  • F. A. Gries
    • 1
  • H. Berger
    • 1
  • I. Cicmir
    • 1
  • K. Wiefels
    • 1
  • D. Ziegler
    • 1
  1. 1.Diabetes-ForschungsinstitutUniversität DüsseldorfDeutschland

Personalised recommendations